Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence
Open Access
- 1 January 2021
- journal article
- review article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 39 (1) , 64-71
Abstract
Optimizing glycemic control remains a shared challenge for clinicians and their patients with diabetes. Flash continuous glucose monitoring (CGM) provides immediate information about an individual’s current and projected glucose level, allowing users to respond promptly to mitigate or prevent pending hypoglycemia or hyperglycemia. Large randomized controlled trials (RCTs) have demonstrated the glycemic benefits of flash CGM use in both type 1 and type 2 diabetes. However, whereas RCTs are mostly focused on the efficacy of this technology in defined circumstances, real-world studies can assess its effectiveness in wider clinical settings. This review assesses the most recent real-world studies demonstrating the effectiveness of flash CGM use to improve clinical outcomes and health care resource utilization in populations with diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapyNutrition & Diabetes, 2016
- Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefitDiabetic Medicine, 2016
- Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic PatientsBiomarker Insights, 2016
- Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 DiabetesJournal of Managed Care Pharmacy, 2013
- Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs2013
- Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability DataDiabetes Technology & Therapeutics, 2012
- The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes ManagementValue in Health, 2011
- Predictors of Health Care Costs in Adults With DiabetesDiabetes Care, 2005
- THE RELATIONSHIP OF GLYCEMIC EXPOSURE (HBA(1C)) TO THE RISK OF DEVELOPMENT AND PROGRESSION OF RETINOPATHY IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL1995
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995